Literature DB >> 15447986

Lung cancers detected by screening with spiral computed tomography have a malignant phenotype when analyzed by cDNA microarray.

Fabrizio Bianchi1, Jiangting Hu, Giuseppe Pelosi, Rosalia Cirincione, Mary Ferguson, Cathy Ratcliffe, Pier Paolo Di Fiore, Kevin Gatter, Francesco Pezzella, Ugo Pastorino.   

Abstract

PURPOSE: Spiral computed tomography (CT) can detect lung cancer at an early stage, but the malignant potential is unknown. The question is, as follows: do these small lesions have the same lethal potential as do symptomatic tumors? EXPERIMENTAL
DESIGN: We used a cDNA microarray platform and compared the gene expression profile of spiral CT-detected lung carcinomas with a matched case-control population of patients presenting with symptomatic lung cancer.
RESULTS: CT-detected and symptomatic tumors have shown a comparable gene expression profile. Correspondence analysis has demonstrated that nine genes were differentially expressed, although with a high variability across the samples that prevented distinguishing the two groups of tumors. Analysis of these nine genes has suggested that early-detected tumors have higher levels of retinoic acid production and higher expression levels of caveolin 2, matrix Gla, and cystatin A, which are already known to be lost during tumor progression.
CONCLUSIONS: All of the tumors observed are histologically malignant according to the WHO Classification. Early lung cancers that are detected by screening have a gene expression pattern similar to, but not identical to, that of symptomatic lung carcinomas.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15447986     DOI: 10.1158/1078-0432.CCR-04-0619

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  24 in total

Review 1.  Lung cancer screening: an update, discussion, and look ahead.

Authors:  Peter J Mazzone
Journal:  Curr Oncol Rep       Date:  2010-07       Impact factor: 5.075

Review 2.  Lung cancer screening.

Authors:  Peter J Mazzone; Tarek Mekhail
Journal:  Curr Oncol Rep       Date:  2007-07       Impact factor: 5.075

Review 3.  Targeting cancer stem cell pathways for cancer therapy.

Authors:  Liqun Yang; Pengfei Shi; Gaichao Zhao; Jie Xu; Wen Peng; Jiayi Zhang; Guanghui Zhang; Xiaowen Wang; Zhen Dong; Fei Chen; Hongjuan Cui
Journal:  Signal Transduct Target Ther       Date:  2020-02-07

4.  Prognostic value and function of KLF4 in prostate cancer: RNAa and vector-mediated overexpression identify KLF4 as an inhibitor of tumor cell growth and migration.

Authors:  Ji Wang; Robert F Place; Vera Huang; Xiaoling Wang; Emily J Noonan; Clara E Magyar; Jiaoti Huang; Long-Cheng Li
Journal:  Cancer Res       Date:  2010-12-15       Impact factor: 12.701

5.  Altered expression of Krüppel-like factor 4 and β-catenin in human gastric cancer.

Authors:  N Zhang; J Zhang; Z W Wang; L Zha; Z Huang
Journal:  Oncol Lett       Date:  2012-02-28       Impact factor: 2.967

Review 6.  Roles of Krüpel-like factor 4 in normal homeostasis, cancer and stem cells.

Authors:  Paul M Evans; Chunming Liu
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2008-07       Impact factor: 3.848

7.  Loss of epigenetic Kruppel-like factor 4 histone deacetylase (KLF-4-HDAC)-mediated transcriptional suppression is crucial in increasing vascular endothelial growth factor (VEGF) expression in breast cancer.

Authors:  Alpana Ray; Mohamed Alalem; Bimal K Ray
Journal:  J Biol Chem       Date:  2013-08-06       Impact factor: 5.157

8.  MicroRNA-10b promotes migration and invasion through KLF4 in human esophageal cancer cell lines.

Authors:  Yanyan Tian; Aiping Luo; Yiran Cai; Qin Su; Fang Ding; Hongyan Chen; Zhihua Liu
Journal:  J Biol Chem       Date:  2010-01-14       Impact factor: 5.157

9.  Kruppel-like factor 4 is a novel mediator of selenium in growth inhibition.

Authors:  Shuang Liu; Haitao Zhang; Liyu Zhu; Lijuan Zhao; Yan Dong
Journal:  Mol Cancer Res       Date:  2008-02       Impact factor: 5.852

10.  5,5'-Dibromo-bis(3'-indolyl)methane induces Kruppel-like factor 4 and p21 in colon cancer cells.

Authors:  Sung Dae Cho; Sudhakar Chintharlapalli; Maen Abdelrahim; Sabitha Papineni; Shengxi Liu; Jingjing Guo; Ping Lei; Ala Abudayyeh; Stephen Safe
Journal:  Mol Cancer Ther       Date:  2008-07       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.